CART-meso in Mesothelin Expressing Cancers
Phase 1 Completed
19 enrolled
Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer
Phase 1 Completed
19 enrolled
A Pharmacokinetic Study of Zolbetuximab (IMAB362) in Chinese Subjects With Locally Advanced Unresectable or Metastatic Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma
Phase 1 Completed
12 enrolled
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
Phase 1 Completed
12 enrolled 18 charts
Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols
Phase 1 Completed
7 enrolled
Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid Tumors
Phase 1 Completed
19 enrolled 22 charts
Nivolumab and Tumor Infiltrating Lymphocytes (TIL) in Advanced Non-Small Cell Lung Cancer
Phase 1 Completed
20 enrolled 10 charts
CAPAFOUR
Phase 1 Completed
25 enrolled
Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer
Phase 1 Completed
192 enrolled 29 charts
A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat
Phase 1 Completed
298 enrolled
DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein
Phase 1 Completed
12 enrolled 15 charts
Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing
Phase 1 Completed
33 enrolled 18 charts
Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors
Phase 1 Completed
136 enrolled
A Study of PDR001 in Combination With CJM112, EGF816, IlarisĀ® (Canakinumab) or MekinistĀ® (Trametinib)
Phase 1 Completed
283 enrolled
SBRT for Organ Confined Prostate Cancer
Phase 1 Completed
36 enrolled
A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer
Phase 1 Completed
22 enrolled
Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers
Phase 1 Completed
13 enrolled
OnFX
Phase 1 Completed
16 enrolled
Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients
Phase 1 Completed
18 enrolled
SOM 230 and Gemcitabine in Advanced Pancreatic Cancer
Phase 1 Completed
20 enrolled
Phase I Study of Tetrathiomolybdate in Combination With Carboplatin/Pemetrexed in Metastatic Non-small Cell Lung Cancer
Phase 1 Completed
26 enrolled
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or Lymphoma
Phase 1 Completed
19 enrolled
DRibble
Phase 1 Completed
3 enrolled
TKM 080301 for Primary or Secondary Liver Cancer
Phase 1 Completed
1 enrolled
Immunochemoradiotherapy in Patients With Pancreatic Cancer
Phase 1 Completed
11 enrolled
Cancer Vaccine Targeting Brachyury Protein in Tumors
Phase 1 Completed
34 enrolled 19 charts
Combining MLN8237 With Nab-Paclitaxel in Patients With Advanced Solid Malignancies
Phase 1 Completed
34 enrolled
FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma
Phase 1 Completed
15 enrolled
A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma
Phase 1 Completed
2 enrolled
Gem-TABS in Unresectable Pancreatic Carcinoma
Phase 1 Completed
8 enrolled
Effects of STM 434 Alone or in Combination With Liposomal Doxorubicin in Patients With Ovarian Cancer or Other Advanced Solid Tumors
Phase 1 Completed
32 enrolled
Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer
Phase 1 Completed
18 enrolled
Phase I FOLFOX Combination
Phase 1 Completed
18 enrolled
Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination
Phase 1 Completed
24 enrolled
Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA)
Phase 1 Completed
48 enrolled
Talimogene Laherparepvec in Patients With Unresectable Pancreatic Cancer
Phase 1 Completed
17 enrolled 14 charts
Ultrasound-assisted Treatment of Inoperable Pancreatic Cancer
Phase 1 Completed
25 enrolled
Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer
Phase 1 Completed
8 enrolled
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)
Phase 1 Completed
37 enrolled 10 charts
MDX1106-01
Phase 1 Completed
39 enrolled 28 charts
Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Adenocarcinoma of the Breast
Phase 1 Completed
9 enrolled
Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric Adenocarcinomas
Phase 1 Completed
6 enrolled 18 charts
Clinical and Pharmacokinetic Trial of Intra-Abdominal Irinotecan
Phase 1 Completed
42 enrolled
Nab-paclitaxel (Abraxane), Gemcitabine, and Capecitabine (Xeloda) for Pancreatic Adenocarcinoma
Phase 1 Completed
15 enrolled
Safety Assessment of One-hour Infusions of SNS-032 for the Treatment of Select Advanced Solid Tumors
Phase 1 Completed
25 enrolled
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer
Phase 1 Completed
10 enrolled
Effect of Vitamin D and Calcium on Genes in the Colon
Phase 1 Completed
10 enrolled
Evaluation of Stereotactic Radiosurgery For Liver Malignancies
Phase 1 Completed
20 enrolled
Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis
Phase 1 Completed
74 enrolled
Phase I Study of a Monoclonal Antibody for Treatment of Advanced Adenocarcinomas
Phase 1 Completed
30 enrolled